The story of Sildenafil presents a interesting case for observers in the drug sector. While initially a tremendous success, generating vast sums, the patent expiration and the subsequent flood of generic competitors https://pharma647907.estate-blog.com/40569973/the-little-copyright-and-pharma-a-speculative-play